Altace and Mycophenolate mofetil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Altace (ramipril) and Mycophenolate mofetil (mycophenolate mofetil). Common drug interactions include weight increased among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Altace and Mycophenolate mofetil. It is created by eHealthMe based on reports of 99 people who take the same drugs from the FDA, and is updated regularly.

What is Altace?

Altace has active ingredients of ramipril. It is often used in high blood pressure. eHealthMe is studying from 23,681 Altace users. Check the latest studies of Altace.

What is Mycophenolate mofetil?

Mycophenolate mofetil has active ingredients of mycophenolate mofetil. It is often used in myasthenia gravis. eHealthMe is studying from 93,460 Mycophenolate mofetil users. Check the latest studies of Mycophenolate mofetil.

On Jul, 13, 2026

99 people who take Altace and Mycophenolate mofetil together, and have interactions are studied.

Altace and Mycophenolate mofetil drug interactions.

What are the common drug interactions of Altace and Mycophenolate Mofetil, by gender? *:

female:

Weight increased
White blood cell count decreased
Alanine aminotransferase increased
Blood alkaline phosphatase increased
Cystitis (inflammation of the wall of the bladder)
Multiple fractures
Arthropathy
Blood immunoglobulin a decreased
Blood immunoglobulin g increased
Blood immunoglobulin m increased

male:

Drug ineffective
Body temperature decreased
Microscopic polyangiitis (inflammation involving multiple blood or lymph small-vessel)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Blood pressure fluctuation
Aortic valve replacement
Multi-organ failure (multisystem organ failure)
Post procedural haemorrhage (post procedural bleeding)
Shock haemorrhagic (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin due to excess bleeding)
Alopecia (absence of hair from areas of the body)

What are the common drug interactions of Altace and Mycophenolate Mofetil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Extremity contracture (permanent shortening of a muscle or joint of arms and legs)
General physical health deterioration (weak health status)
Injury
Internal injury
Joint contracture (a permanent shortening of a muscle or joint)
Joint range of motion decreased (disease of joint movement)
Mobility decreased (ability to move is reduced)
Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)

30-39:

Antineutrophil cytoplasmic antibody positive
Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
Microscopic polyangiitis (inflammation involving multiple blood or lymph small-vessel)

40-49:

Alopecia (absence of hair from areas of the body)
Arthralgia (joint pain)
Cardiomegaly (increased size of heart than normal)
Cardiomyopathy (weakening of the heart muscle)
Cataract (clouding of the lens inside the eye)
Cytomegalovirus infection
Deformity (disfigurement)
Drug abuse
Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
General physical health deterioration (weak health status)

50-59:

Aortic valve replacement
Multi-organ failure (multisystem organ failure)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Post procedural haemorrhage (post procedural bleeding)
Shock haemorrhagic (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin due to excess bleeding)
Blood glucose increased
Chronic kidney disease
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Nephrogenic anaemia (anaemia due to kidney disease)

60+:

Drug ineffective
Myelosuppression (a decrease in the production of blood cells)
Colitis microscopic (inflammation of colon with diarrhoea and abdominal cramps)
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
Eye disorder
Glaucoma (increased fluid pressure in the eye with vision loss)
Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle)
Herpes zoster
Insomnia (sleeplessness)

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 62 people, 62.63%
Diabetes: 60 people, 60.61%
High Blood Cholesterol: 23 people, 23.23%
Myositis (inflammation of the muscles): 11 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Altace and Mycophenolate mofetil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously